Impact of a small dose of Dexmedetomidine on postoperative recovery of total intravenous anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006843

Enrollment

Unknown

Registered

2015-07-29

Start date

2015-07-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

quality of recovery from anesthesia

Interventions

D group :Intravenous push Dexmedetomidine 0.5 micrograms/kg

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Elective patients with gynecological surgery, ASA I-II, Age 18 - 65 years old.

Exclusion criteria

Exclusion criteria: The exclusion criteria included original cardiopulmonary dysfunction, chronic hepatic or renal insufficiency, obvious arrhythmia and known of a history of allergy to Dexmedetomidine, intraoperative appear allergic reactions associated with Dexmedetomidine, the operation time is shorter than 40 min or longer than 120 min.

Design outcomes

Primary

Measure	Time frame
Extubation time;Recovery time;Ramsay sedation score;SPO2;heart rate;NIBP;	—

Countries

China

Contacts

Public ContactHuang Shaoqiang

timrobbins71@163.com+86 13918210787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026